Latest in Eli Lilly beats on earnings even as weight loss, diabetes drug sales fall short
Sort by
2,254 items
-
1/14: CBS Evening News
Pete Hegseth faces Senate grilling in confirmation hearing; Princess Catherine says cancer is in remissionCBS News - Jan. 15 -
Hallucinations in AI: How GSK is addressing a critical problem in drug development
Hallucinations are a persistent problem in healthcare. Here's how GSK is using test-time compute scaling to improve its gen AI systems.VentureBeat - Jan. 14 -
Top 3 drug insurers reaped billions as their drug middlemen inflated prices, FTC alleges
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from ‘excess’ prescription price hikes of 1,000% or more.NBC News - Jan. 14 -
Los Angeles Is Being Crushed Under the Weight of Inaction
At this point, we’d take concepts of a plan.The New York Times - Jan. 14 -
Eli Lilly CEO expects new weight loss pill to be approved next year
Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which dominate the weight loss drug market.CNBC - Jan. 13 -
Eli Lilly strikes deal for cancer treatment, gives timeline for weight loss pill
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.CNBC - Jan. 13 -
Johnson & Johnson makes $15 billion bet on mental-health drugs
Pharma giant Johnson & Johnson is buying Intra-Cellular Therapies, eying sales growth above analysts’ expectations through 2029.MarketWatch - Jan. 13 -
Even Adults May Soon Be Vulnerable to ‘Childhood’ Diseases
Outbreaks among the unvaccinated are a predictable consequence of falling immunization rates. But even vaccinated adults may be vulnerable to some illnesses.The New York Times - Jan. 13 -
GSK to buy US cancer drug firm IDRx for up to $1.15bn
Massachusetts-based company is working on new treatments for gastrointestinal cancers. Business live – latest updates GSK has struck a deal worth up to $1.15bn (£950m) to acquire a ...The Guardian - Jan. 13 -
Falling Child Vaccinations
U.S. vaccination rates against once-common childhood diseases are falling.The New York Times - Jan. 13 -
'I feel blessed to get weight-loss jab' - but can the NHS afford it for all?
We meet some of the first NHS patients, as expert says funding everyone eligible would "bankrupt" the service.BBC News - Jan. 13 -
-
Marc-Andre Fleury makes 36 saves as the short-handed Wild beat the Sharks 3-1
Marc-Andre Fleury made 36 saves, Marco Rossi and Matt Boldy scored, and the short-handed Minnesota Wild beat the San Jose Sharks 3-1ABC News - Jan. 12 -
1/10: CBS Evening News
Crews make slow progress battling Southern California wildfires; How a beloved geology professor's bond with a former student transcends illnessCBS News - Jan. 11 -
What we learned as short-handed Warriors fall to red-hot Pacers
Pat Spencer and Buddy Hield combined to score 34 points, but it wasn't enough as the short-handed Golden State Warriors ran out of gas against the Indiana Pacers on Friday night.Yahoo Sports - Jan. 11 -
Regulators Tell Baltimore Drug Program to ‘Cease and Desist’
Maryland issued the order after an investigation by The New York Times and The Baltimore Banner traced overdoses and deaths to an addiction program offering free housing.The New York Times - Jan. 11 -
Evening Report — Trump plots governing strategy
👨🏼⚖️Plus: Judge holds Giuliani in contempt {beacon} Evening Report Friday, Jan. 10 © Evan Vucci, Associated Press Trump turns to governing as investigations fizzle PRESIDENT-ELECT TRUMP IS ...The Hill - Jan. 10 -
Walgreens shares soar 27% on big earnings beat, as drugstore chain cuts costs
Walgreens maintained its fiscal 2025 adjusted earnings guidance, but did not include a sales outlook in its release.CNBC - Jan. 10 -
U.K.’s First Drug Consumption Center Is Set to Open in Glasgow
Scotland, which has the highest rate of recorded drugs deaths in Europe, is opening a new facility for users to inject illegal drugs under medical supervision.The New York Times - Jan. 10 -
High cost of weight loss drugs drives employers to require nutrition counseling, in boost for startups
Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss management program.CNBC - Jan. 10 -
1/9: CBS Evening News
Los Angeles officials face questions, criticism as out-of-control wildfires continue to rage; How to help Southern California wildfire victimsCBS News - Jan. 10 -
'Three-weight champion & retire by 30' - Dubois dreams big
World champion Caroline Dubois plots her journey to superstardom within six years and addresses the publicised family feud with her father and brother.BBC News - Jan. 10 -
Power Rankings: How far does Tennessee fall after historic loss?
How do Florida's and Tennessee's fortunes change after the Gators' dominant showing?ESPN - Jan. 9 -
Inside the UK's first legal drug consumption room
The Thistle will open its doors next week after nearly a decade of deadlock over drug laws.BBC News - Jan. 10 -
Medicare can now cover Eli Lilly's Zepbound for sleep apnea, Health Department agency says
It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other insurance plans for weight loss.CNBC - Jan. 9 -
Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face an uncertain future in the incoming Trump administration.NBC News - Jan. 9 -
Medicare can cover Zepbound for sleep apnea, creating a significant opportunity for Eli Lilly
Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment costs about $1,000 a month without insurance.MarketWatch - Jan. 9 -
As Art Sales Fall, Christie’s and Sotheby’s Pivot to Luxury
With both supply and demand for big-ticket art in a slump, Sotheby’s and Christie’s are making major bets on selling handbags, classic cars and niche experiences.The New York Times - Jan. 9 -
Smith dumps Diageo stake over impact of weight-loss drugs on alcohol demand
Veteran stockpicker sells shares in spirits brand because drinks sector is being ‘impacted negatively’Financial Times - Jan. 9 -
1/8: CBS Evening News
Firestorm brings death, destruction to Los Angeles County; Los Angeles fire official on the challenges crews are facingCBS News - Jan. 9 -
Evening Report — Trump investigations speed to an end
Plus: 🔥Thousands flee as Los Angeles burns {beacon} Evening Report © AP Photo: Charlie Neibergall, Jacquelyn Martin Trump's legal troubles barrel toward a conclusion THE INVESTIGATIONS AND ...The Hill - Jan. 8 -
Eli Lilly's lead in the obesity race has grown. Its recent stock performance says otherwise
Eli Lilly has been one of the worst-performing Club stocks over the past six months.CNBC - Jan. 8 -
Ange: Even Salah would struggle at Tottenham
Ange Postecoglou has said that even Liverpool forward Mohamed Salah would struggle in his Tottenham side.ESPN - Jan. 8 -
GSK nears $1bn deal for biotech developing drug for rare tumour
IDRx tests treatment for digestive system cancer that affects 4,000 to 6,000 people a year in USFinancial Times - Jan. 8 -
1/7: CBS Evening News
Strong winds fuel rapidly expanding wildfires in Southern California; Peter Yarrow, of Peter, Paul, and Mary, dies at age 86CBS News - Jan. 8 -
Breakthrough drugs herald ‘new era’ in battle against dementia, experts predict
Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally. Pills that prevent Alzheimer’s disease or blunt its effects are on the horizon, ...The Guardian - Jan. 8
